DGAP-Adhoc: MeVis Medical Solutions AG: Outstanding purchase price payment reduced by EUR 1.6 million / Adjustment of forecast for the current fiscal year

| Source: EQS Group AG EQS Group AG 

MeVis Medical Solutions AG  / Key word(s): Change in Forecast

19.12.2012 18:18

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bremen, December 19, 2012 - MeVis Medical Solutions AG [ISIN:
DE000A0LBFE4], a leading provider of medical imaging software, has managed
to reduce the payment of the last tranche for the acquisition of the 49 %
stake in MBS KG from originally EUR 3.0 million to EUR 1.4 million in a
constructive dialogue with Siemens on the interpretation of a contract
term. This payment is due at the end of 2012. Furthermore, a license credit
to be granted by MeVis until 2015 is reduced by approximately EUR 0.4
million. This results in an overall reduction of liabilities by
approximately EUR 2.0 million which will be booked against goodwill thus
having no impact on earnings.

On that basis and on the basis of the current business development the
forecast for the current fiscal year will be adjusted:

  - For 2012 consolidated sales now will be expected to be slightly lower
    compared to the previous year.

  - Through sustainable cost reductions both in personnel costs as well as
    other operating expenses a significantly increased consolidated EBIT of
    at least EUR 2 million is expected.

  - Even considering the purchase price payment, a positive cash flow will
    be expected for 2012.

The Annual Report 2012 and the forecast for the next fiscal year will be
published in April 2013.


19.12.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      MeVis Medical Solutions AG
              Universitätsallee 29
              28359 Bremen
              Germany
Phone:        +49 421 224 95 0
Fax:          +49 421 224 95 11
E-mail:       ir@mevis.de
Internet:     http://www.mevis.de
ISIN:         DE000A0LBFE4
WKN:          A0LBFE
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------